mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
0.01 |
mRNA |
CGP-082996 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
PD-0332991 |
CCLE |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |